The company says it's not just older horses suffering from joint disease, 36% of horses developed the condition by the time they were eight years old.
In the survey, 69% of horses needed up to five visits to their veterinary surgeon for treatment, while 21% needed as many as ten visits. Horse owners spent an average of £2,104 treating their horse’s joint condition while 5% spent more than £7,500 on the problem.
In addition, 53% said they've missed up to ten competitions due to joint disease, with 17% missing more than 20 competitions.
The survey revealed that joint problems are an ongoing concern for many. 76% of owners said they worry about their horse developing osteoarthritis and 30% had retired a horse earlier than expected owing to joint disease. In addition, 84% admitted that they would not buy a horse if they knew it had joint problems.
In terms of joint care, 74% of respondents said they give their horse a joint supplement. 69% check their horse's legs daily and 90% implement post-competition leg care measures.
Cavalor’s Lieselot Hamerlinck said: "It is good to see that so many horse owners are using a joint supplement but it’s important that they understand what to look for when choosing which product to use. They should look for anti-inflammatory products, not just joint support and for clinical evidence on any product claims. It’s not just about giving a joint supplement every day, it’s more about giving the right product tailored to the horse’s individual needs.
"Also horse owners should be mindful that it is equally important, if not more so, to take proper care of their horse’s joints all year round, not just during competition."
For further information, visit www.cavalor.com.
Reference
Norbrook Laboratories has launched powder and paste versions of Noroquin - its glucosamine-based supplement range - for horses.
Noroquin contains the active ingredients glucosamine, chondrotin sulphate, manganese sulphate, zinc sulphate, absorbic acid and N-Acetyl-D-Glucosamine, designed to maintain healthy cartilage, promote joint management and keep horses mobile.
Michelle Jones, Brand Manager at Norbrook said: "In recent years, horses are increasingly competing longer which means maintaining the longevity of the horse is vitally important for long term success. 60% of lameness is related to osteoarthritis and is regarded as the major cause of disability in the athletic horse.
"With increasing reliability on nutritional supplements and concerns from horse owners about their aging horse, our Noroquin for Horses range can be offered as alternative to traditional pain management products indicated for musculoskeletal ailments or alongside them as a completely safe addition to a joint management programme."
Michelle added: "The Noroquin paste for horses is a highly palatable apple flavored paste that can be fed directly to the horse as a tasty treat and offers an alternative to traditional methods while the Noroquin powder for Horses is a highly palatable powder that can be mixed with food. The product is available in handy single-use sachets for accurate dosing and waterproof 1kg tubs."
Noroquin Powder and Paste for Horses joins the newly launched tasty tablets for dogs and cats and powder for cats in the Noroquin range. It is available from wholesalers.
Stephen, who works for the PDSA, wowed the judges with his photograph of a pair of wild ponies, entered into the 'All creatures great and small' category. He said: "I had a great day out photographing these wild grey ponies on a similarly grey January dayon the Long Mynd, a heath and moorland plateau in the Shropshire hills. I was simply out on a photo walk to take in the scenery and wildlife, look for a good shot and get a breath of fresh air; I’m chuffed that the judges have selected it as a category winner!"
Peter, who graduated from Nottingham University this summer and works at a practice in Bicester, won in the ‘Human:animal bond’ category with his entry: 'Best part of a job', which shows a laid-back 10-week-old cocker spaniel puppy lounging contentedly on his lap. Peter said: "This photo was taken whilst on placement in Chipping Norton as a student. The puppy was in to have her second vaccinations and a general health check after she had been with her new family for a week, and she was on my lap so that I could calm her, examine her, and socialise her. Working in the veterinary world is by no means easy, which is why moments like this are so important. Everyone needs a puppy cuddle!"
This year, the judging panel included David Tipling, one of the world's most widely published wildlife photographers. He said: "Helping to judge this year’s competition was for me a fascinating insight into a vet’s working life. Photography, like any art form, is subjective, but I was looking for pictures that had been composed and thought about and most importantly would linger in the mind long after they had been viewed. Much debate and discussion led us to some clear favourites from which to choose two overall winners."
"The winning shot [by Stephen] is beautifully composed, has a symmetry and used the dark and light tones of the ponies to complement each other, resulting in a striking image that we were all drawn to. I was drawn to [Peter’s] image partly by its abstract nature; on first view it is not obvious the dog is on someone’s lap. It is a strong, engaging image and because of that slightly abstract feel means it stays long in the memory.”
Peter and Stephen each receive £250 worth of gift vouchers from John Lewis.
CVS says that in the USA, the veterinary profession is the fifth highest profession for non-fatal injuries, with equine veterinarians sustaining an average of eight serious injuries during their career.
‘The context, consequence and prevention of veterinary workplace injuries: a qualitative and quantitative study in the UK’ will be undertaken at the University of Liverpool in collaboration with CVS colleagues as part of its Clinical Research Awards.
The study will run for three years, supported by £74,400 of CVS funding.
The research will investigate what veterinary injuries are, what context they occur in and what their consequences are.
It will look to highlight areas of the profession where injury prevention training and strategies can be developed and adopted to improve the safety of working in veterinary practice.
For the first phase, University of Liverpool researchers have rolled out the largest ever survey to explore veterinary workplace injuries with over 5,000 CVS staff UK-wide.
The survey investigates how veterinary professionals define injuries, their specific causal mechanisms, and why individuals do or do not report injuries or seek medical treatment.
The survey will be followed by an independent audit of CVS’ accident reporting system.
The results of these two activities will lead to the development of a suite of industry leading ‘open access’ educational tools aimed at promoting injury awareness and prevention to help drive behaviour change and support injury avoidance.\
The research project is being led by Dr. John Tulloch, a Research Fellow and European Specialist in Veterinary Public Health, at the University of Liverpool.
Collaborators include CVS Head of Health and Safety Rebecca Jackson and Director of Learning, Education and Development Dr Martin Whiting.
John said: “Injuries that occur within veterinary practice can tragically at times be life-changing and are often avoidable.
"Currently we do not know some critical details that would help to improve safety within the veterinary workplace.
"If we can better understand these details, we will be able to develop and strengthen prevention measures through policy, education, and training.
"We anticipate that this project will result in safer workplaces within the wider veterinary community and, indirectly, in improved animal treatment through a fitter, healthier and safer profession.”
Novartis Animal Health has launched Zolvix, billed as the first truly novel anthelmintic class for livestock to be launched in more than 25 years, together with a new drenching system designed to make drenching faster, easier and more accurate.
Zolvix contains a new active ingredient, monepantel, which kills all key sheep gastro-intestinal nematodes (roundworms), including those resistant to the existing treatments.
According to the company, the development of this new drench follows the persistent challenge from worms that have developed resistance to the three other classes of drench - white (benzimidazole or 1-BZ), yellow (levamisole or 2-LV) and clear (macrocyclic lactone or 3-ML) and combinations of these. Zolvix has a unique mode of action and so forms a fourth generation of anthelmintic, which will be known as the 4- AD, or orange drench class
Novartis Animal Health has prioritised the UK and Ireland as key launch countries for Zolvix to provide their sheep farmers with an answer to the pressing challenge of increasing anthelmintic resistance.
Lesley Stubbings, an Independent sheep consultant and Sustainable Control of Parasites in Sheep (SCOPS) panel member, said: "Resistance has become an ever increasing threat since the last new anthelmintic group was introduced to the UK market more than 25 years ago. Zolvix offers farmers a valuable opportunity to maintain good worm control and prolong the effective life of the existing products. Following the SCOPS guidelines to carefully integrate Zolvix into worm control strategies, before the other groups fail, will allow our sheep industry to reap the full benefits of this new novel group."
A study carried out by Novartis in conjunction with the Hopkirk Research Institute showed that Zolvix treated sheep gained 33.5%, or 2.8 kg deadweight, more than sheep treated with a drench to which they were resistant.
Novartis Animal Health Brand Manager Simon Harris said: "Parasite resistance is a growing problem that decreases the productivity of sheep of all ages. Many veterinarians and farmers are concerned about this, with an increasing number of farmers reporting resistance to the three groups of wormers that have been available up to now, so the introduction of Zolvix is very timely."
At the same time, the company has also launched an award-winning new drenching system designed to offer 'a superior drenching experience for both animal and operator'. The new Optiline Drencher and Optivix backpack system were developed in collaboration with drenching specialists Simcro Tech Ltd.
The Optiline Drencher has already won several design and engineering awards, including a bronze award in the 2009 NZ BEST design awards, a coveted International Forum (IF) 2010 product design award from Germany and the prestigious Bayer Innovators Award for design and engineering.
It was also a finalist in the New Zealand Agritech Innovation Awards reached the finals in three categories of the 2009 New Zealand Trade and Enterprise International Business Awards.
The Optiline drencher is coupled with a durable, light Optivix backpack that has been specially tailored to provide left or right-handed operators with the same wide range of adjustment. It also has two drench cradles - at chest and hip level - to ensure maximum comfort.
Mr Harris said: "This drencher is best appreciated during use. Contact your local Novartis Animal health representative to arrange a trial."
The 2009 Petplan Veterinary Awards are now underway, and you may now nominate those exceptional colleagues in the veterinary profession who you feel deserve to be officially recognised for all their hard work.
This year will be a double celebration as Petplan celebrates its 10-year anniversary of the awards. The company invites you to nominate a colleague (or your entire team) for an award in one of four different categories.
Nomination forms, posters, and leaflet dispensers are now available in practices. Forms are also available online at www.petplan.co.uk/vetawards. You may order more nomination forms by emailing vetawards@petplan.co.uk or calling 0845 678 1063.
Simon Wheeler, head of marketing for Petplan, said: "Nominating your colleagues for an award is a fantastic way of expressing your appreciation. Veterinary practices are dedicated to animal welfare and at Petplan we believe that their invaluable care and support deserves to be recognised. The 10th annual Petplan Veterinary Awards will recognise this and celebrate those exceptional professionals."
Nominations close February 6th 2009.
Canaural contains fusidic acid, framycetin and nystatin for their antibacterial and antifungal effects against the most common organisms associated with otitis externa.
Fusidic acid has skin penetrating properties and is active against staphylococci and streptococci1. Framycetin is active against Gram negative species. Dechra says the combination of the two provides an enhanced antibacterial effect on the most common bacterial cause of canine otitis2.
Nystatin is active against malassezia and prednisolone helps to provide anti-inflammatory and anti-pruritic action.
Dechra Brand Manager Carol Morgan said: “The reintroduction of Canaural to the veterinary treatment market means that once again veterinarians have this reliable and effective treatment available to tackle one of the most common canine complaints.
"Canaural is a tried and tested product and a recent study showed that fusidic acid is highly efficacious against both methicillin sensitive and methicillin resistant strains of Staphylococcus pseudintermedius3. Canaural remains as relevant today as it has ever been."
Canaural comes in 15 ml and 25 ml bottle sizes and is now available in veterinary wholesalers.
References
It's National Veterinary Nurse Week from 26th October to 1st November and vet nurses across the country will be raising awareness of the important job they do in caring for the nation's pets. Bonny Millar CVT(USA), RVN, REVN, Vice President of the BVNA and VN week organiser has called for vets and practice managers to support the initiative.
She said: "This is an ideal opportunity for practices to use their nurses to full effect. A lot of our efforts go on behind the scenes and so nurses are sometimes not fully appreciated by pet owners. We are encouraging practices to get their nurses out at front of house, running clinics and offering clients help and expert advice. Reducing barriers and educating the wider public about the role of the vet nurse can only be a good thing. Vets and practice managers know what a great contribution a good vet nurse can make to the practice and we would love to see them make a big effort to be ‘loud and proud' during National VN Week."
Bonnie added: "Last year hundreds of veterinary nurses took part in VN Week and we raised over £5000 for charity. This year our nominated charity is the Animal Cancer Trust so I hope practices really support their nurses in helping raise money for this important cause."
The British Veterinary Nursing Association is co-ordinating the various activities going on around the country and has arranged two pet health check days in Roundhay Park in Leeds on 26th October and Kensington Gardens in London on 1st November, sponsored by Hill's Pet Nutrition. Nurses are also being encouraged to make a special effort with prizes on offer thanks to sponsors Animalcare (Satellite Navigation system), Merial (lap top) and Vetoquinol (Nintendo Wii) for the most innovative event, most public involvement and most money raised for charity.
Further information and a registration pack is available from the BVNA http://www.bvna.org.uk/ (Tel 01279 408644). Any members of the practice interested in keeping up to date with the activities planned for VN Week can also visit the blog for the event at http://vnweek.wordpress.com/
Micro-nutrition specialist Agrimin has launched All-Trace Biotin Gold, the seventh bolus in the company's All-Trace range.
The new bolus is the result of extensive in-house research and development which aimed to formulate a cost-effective, micro-nutrition bolus suitable for dry cows and heifers at risk from lameness, which affects up to 20 per cent of the UK national herd. According to Agrimin, the relationship between Biotin and its benefits on ruminant hoof health is receiving increasing attention. The company says it is the first micro-nutrition specialist to directly address this livestock health issue by using a bolus.
The Biotin Gold bolus for dairy cows and heifers delivers the target level of 20 mg per head, per day of Biotin over 120 days. In addition, the bolus also delivers the full, daily requirement of copper, cobalt, selenium and iodine as well as levels of zinc, manganese and vitamins A, D3 and E.
Administration is simple and convenient during the drying off period as many livestock are already going through a crush to have their feet trimmed and undergo other healthcare routines such as intramammary treatments.
For dry cows, two boluses are given to each cow at the point of drying off. They lie in the rumen/reticulum and slowly dissolve from a constant surface area providing a continuous and regular supply of trace elements and vitamins to the animal. The boluses dissolve completely and leave no residue in the rumen.
Agrimin says heifers respond very well to Biotin supplementation and studies have shown that supplying Biotin in the later stages of pregnancy produces the most effective results. This late stage of pregnancy is also the critical period for the transfer of vital nutrients from mother to calf and so the trace element content of All-Trace Biotin Gold will benefit both animals. Two boluses are given to each heifer at around three months pre-calving.
All-Trace Biotin Gold is available in packs of 20 boluses, which will supplement 10 cows or heifers at a cost of around £9.50 per animal for two boluses. For more information about bolus technologies and micro-nutrition, please visit www.agrimin.com or call 01652 688046.
The Kennel Club has written to veterinary surgeries in the UK to remind them to report caesarians and operations carried out on Kennel Club registered dogs, to help monitor and improve pedigree health.
The letter reminds vets that any operations which alter the natural conformation of a Kennel Club registered dog should be reported, as owners will need to apply for permission to compete with that dog at Kennel Club licensed shows. Vets are also asked to report caesarians as the Kennel Club will not register a litter from a bitch that has had two subsequent caesarians.
The Kennel Club says that information submitted by vets will ultimately help to improve the health of pedigree dogs as it 'provides information regarding breeding lines which may pass on certain defects and helps to deter breeders from breeding from animals with hereditary problems.'
The letter informs vets that breeders sign a declaration when registering their litter with the Kennel Club, which means that the vet will never be breaching confidentiality when reporting such operations. The declaration says: "I/we confirm and agree that any veterinary surgery performing a caesarian section and/or operation on any of my/our dogs in such a way that the operation alters the natural conformation of the dog or any part thereof may submit a report to the Kennel Club."
The declaration, regarding the reporting of operations which change natural conformation, was made a condition of Kennel Club registration in 1990 and caesarians were added to the declaration in 2010.
Caroline Kisko, Kennel Club Secretary, said: "The veterinary profession and the Kennel Club both hold valuable information about pedigree dogs but by sharing this information we will get a much more accurate picture about dog health.
Although some vets report operations to the Kennel Club this is not a uniform practice, but we hope this reminder will help to ensure that we work more closely together in the future."
Vets have been sent a copy of the reporting form that they should use and the link to where the forms can be downloaded from the Kennel Club website www.thekennelclub.org.uk/item/3310. The BVA has also produced a list of frequently asked questions about veterinary reporting at www.bva.co.uk/publications_and_resources/Forms.aspx
Zoetis has launched Suvaxyn Parvo/E, a combined vaccine which it says provides the earliest protection of gilts against parvovirus and erysipelas.
Parvovirus and erysipelas infections occur primarily in gilts and sows, negatively impacting their reproductive success and the health of their litters - inevitably reducing profitability.
Nigel Lodge, National Veterinary Manager for Zoetis, said: "The combined vaccine will help ensure the health of gilts and sows is not affected by these two infections which are widespread in the pig herd.
"Suvaxyn® Parvo/E gives the earliest protection so that the ability to vaccinate gilts at five months of age will help ensure a good start to their reproductive life. Up to half of all pigs may be carriers of erysipelas and importantly the vaccine has licensed efficacy against both Erysipelothrix serotypes 1 and 2.
"This brings another vaccine to our portfolio, making it one of the largest in the pig sector and confirming the ongoing commitment of Zoetis to the health and welfare of pigs."
Suvaxyn® Parvo/E is an inactivated combination vaccine approved for immunising gilts and sows to prevent reproductive disorders caused by porcine parvovirus and reduce clinical signs caused by Erysipelothrix rhusiopathiae.
Primary vaccination is recommended from five months of age, with two injections given three to four weeks apart, ensuring the second dose occurs at least four weeks before mating. Revaccination should take place three to four weeks before each subsequent mating.
The vaccine comes in 10-dose and 2 X 25-dose packs. For more information, contact your Zoetis Pig Key Account Manager.
Saliva was collected from 237 horses at the UK welfare charity, Bransby Horses, where EquiSal Tapeworm saliva testing was used to inform on anthelmintic administration over the course of a year. This diagnostic-led approach reduced the use of anti-tapeworm treatments by 86% compared to 6 monthly interval treatment strategies.
Austin Davis Biologics Ltd, the maker of the EquiSal Tapeworm saliva test, says it accurately diagnoses horses with a tapeworm infection, providing a low, borderline or moderate/high diagnosis.
Treatment is recommended for horses with a borderline or moderate/high result2.
In this latest study, the company says most horses diagnosed below the treatment threshold in the first saliva test remained below the threshold in the following two tests and 168 horses (71%) required no anti-tapeworm treatment at all.
Importantly, no increase in tapeworm infection prevalence was observed during the study period and only seven horses received treatment following all three saliva tests, suggesting that some horses are more susceptible to tapeworm infections.
The EVJ has prepared a podcast summarising the study findings here: https://evj.podbean.com/e/evj-of-the-hoof-podcast-no-1-march-2018-use-of-saliva-based-diagnostic-test-to-identify-tapeworm-infection-in-horses-in-the-uk/.
The study authors have also prepared a video abstract which can be viewed at https://vimeo.com/254338616 .
EquiSal saliva collection kits are available at trade prices to veterinary practices and SQPs. Contact enquiries@equisal.com or visit www.equisal.com for more information.
This year the College is seeking nominations for six awards:
The Queen’s Medal: the highest honour that can be bestowed upon a veterinary surgeon for a highly distinguished career with sustained and outstanding achievements throughout.
The Veterinary Nursing Golden Jubilee Award: this award is aimed at veterinary nurses who have had a sustained and distinguished career, who can demonstrate a leadership role within the profession and who can act as an ambassador for the value of veterinary nurses and their work.
RCVS International Award: this award is for vets, vet nurses or laypeople who work internationally, from either within or outside the UK, in making an outstanding contribution to, for example, raising veterinary standards, veterinary education and improving animal health and welfare.
RCVS Impact Award: this award is for vets or vet nurses who have recently, or are currently, undertaking a project, initiative or similar that has a significant impact on the profession at large, animal health or welfare, or public health. Such impact could have been made through any field of veterinary endeavour, including clinical practice, research, education or veterinary politics.
RCVS Inspiration Award: this award is for vets or vet nurses at any stage of their career who have demonstrated the ability to inspire and enthuse others consistently throughout. It is open to those who have inspired and motivated individuals anywhere within the profession and recognises those who have gone ‘above and beyond’ what may normally be expected from a professional colleague.
Honorary Associateship: this honour is conferred to a small number of laypeople each year, in recognition of their special contribution to the veterinary sphere. It recognises the full range of individuals who contribute to the veterinary sphere including scientists, lecturers, journalists, charity-workers, farriers, farmers and those involved in the commercial field.
For this year’s honours and awards nomination period, the College has produced a video using footage from Royal College Day 2018, featuring interviews with those who were recognised with RCVS honours and awards on the day.
The video is available to view at www.rcvs.org.uk/honours where you can also download further information and guidance about the criteria for nominators and nominees for the awards, as well as how to make nomination.
Dr Niall Connell, RCVS Junior Vice-President, is taking the lead in promoting the awards this year. He said: "Throughout my time in the veterinary profession, and particularly since joining RCVS Council, I have met so many veterinary nurses and veterinary surgeons who are truly inspiring individuals.
"The RCVS honours and awards scheme is a perfect opportunity to celebrate some of the individuals that have done or are doing something really special – whether that’s by inspiring their colleagues and peers or doing things that benefit animal health and welfare or society at large.
"Across all six awards there really is something for everyone – vets and veterinary nurses at all stages of their careers as well as laypeople are all up for recognition and so I’d strongly encourage everyone to think about someone they know who deserves recognition and get in touch.”
The deadline for nominations is Friday 18 January 2019.
For an informal talk about the awards and how to make a nomination you can contact Peris Dean, Executive Secretary, on p.dean@rcvs.org.uk or 020 7202 0761.
Membra is a transparent, water-resistant, non-toxic, biodegradable bandage replacement consisting of a hydrogel polymer which can be applied to open wounds.
It is initially applied as a liquid and quickly gels into a thin, flexible layer over the site.
The initial liquid phase of Membra allows it to cover open and irregular spaces as well as suture lines and it dries in minutes to form a barrier that covers and protects the incision site or wound.
Being transparent, Membra allows the wound to be seen by the veterinary team and pet owners.
Membra lasts for up to 14 days and naturally biodegrades over time.
Animus says that Membra lowers the risk of infection or dehiscence.
The company also says that hydrogel polymer has been shown to replace the need for adhesive bandaging on suture lines following major TPLO surgery.
A study concluded that the polymer did not appear to raise the prevalence of incisional complications after TPLO surgery and lasts for 14 days, rather than 24-48 hours with traditional bandaging1.
Nick Butcher MRCVS, owner of Animus Surgical in the UK, said: “Regular bandaging of open wounds can be costly, time-consuming and stressful for owners and their pets, requiring frequent visits to the practice.
"The bandaging of some open wounds can be impossible because of the location of the lesion or the affected species (e.g. exotic or aquatic animals) and more aggressive or nervous patients may require sedation.
"Used bandages also add to the volume of clinical waste generated by the practice which requires incineration
“We are therefore delighted to launch Membra to veterinary teams in the UK.
"It has been very successful in the U.S. and we already have a number of UK vets using the product as Membra can positively affect the outcome of open wound management across a range of species, without the need for regular bandage changes.”
To find out how to apply Membra, a range of YouTube videos are available showing a selection of case examples: https://youtube.com/@sutureseal5917.
www.animussurgical.com.
Janssen Animal Health has launched Domosedan Gel, an oromucosal gel for the sedation of horses.
Janssen says Domosedan Gel, which contains 7.6 mg/ml (40mcg/kg) detomidine, induces sedation and analgesia with the efficacy and recovery comparable to Domosedan injection. Domosedan Gel is administered under the horse's tongue, so it is rapidly absorbed.
The company also says Domesedan Gel can replace physical restraint and improve safety during treatments, diagnostics and transport, and that the gel is ideal for horses that are nervous or needle-shy and when owners need more control during clipping, shoeing, dental treatments and boxing.
Nicki Glen, marketing manager at Janssen Animal Health said: "Domosedan Gel is proven to be both effective and easy-to-administer with 98% of horses accepting the gel and owners finding it easy and convenient to use.
"The gel starts to be absorbed immediately and demonstrates a reliable sedatory effect and high safety margin, making it an ideal solution for sedation and restraint when performing non invasive procedures on horses."
For further information, please contact your Janssen Animal Health territory manager.
Ceva Animal Health has launched Cardio Academy. The company says it's the first international cardiology e-learning programme offering CPD from leading international specialists.
The programme can be accessed at www.cardioacademy.cevalearn.com. It consists of a series of impressively well-produced interactive multimedia presentations lasting around 30 minutes, at the end of which you can download a CPD certificate.
The first two sessions, which are now available online, cover the Pathophysiology of Mitral Valve Disease, by Adrian Boswood, and Clinical Examination of the Cardiac Dog, by Gérard Le Bobinnec.
Product manager, Fraser Broadfoot MRCVS, said: "There have been many advances in the diagnosis and treatment of heart failure in recent years. The aim of this website is to become a practical and up-to-date resource on the management of heart failure in practice."
CVS has announced the acquisition of four further veterinary practices bringing the total number of practices it owns across the UK to 92 operating from 253 sites.
The latest practices to join CVS are: Crescent Veterinary Clinic Ltd, Melton Mowbray; Miller & Swann Veterinary Surgery, Elgin; West Mount Vets, Halifax and Anchorage Veterinary Hospital, Acle.
CVS now employs more than 2,300 staff at its veterinary practices and surgeries across the UK and in its related veterinary businesses, including an online pharmacy, two pet crematoriums and six veterinary laboratories.
The new products are:
Leon Wright, Managing Director, said: "At Vet Direct, we’re always looking for ways to improve our service – making small changes which will have a big impact on the levels of care our clients can provide.
"We know that vets, veterinary nurses and practice managers don’t always have the time to try out new products before purchasing, and that’s why our dedicated team of sales staff test every item before adding them to our catalogue - ensuring that we only stock the highest quality products."
For more information on any of the new products, visit www.vet-direct.com or call 0800 068 3300.
Mr Wilson faced two charges. The first was that in October 2017, he provided inaccurate information to an insurer in respect of a Labrador he treated by saying that the dog was presented to him with a lame left foreleg on 13 June 2017, when in fact the dog was presented for treatment on 7 June 2017 and that his conduct was therefore dishonest and misleading.
The second charge was that between 17 January 2017 and 17 January 2018 he failed to have any arrangements in place for Professional Indemnity Insurance (a requirement of the Code of Professional Conduct) and then, that between 8 January and 5 December 2019, he failed to respond to reasonable requests from the RCVS regarding his Professional Indemnity Insurance.
Prior to the hearing, Mr Wilson made an application to the Committee to adjourn the hearing subject to the Committee accepting his undertakings to remove himself from the Register and never to apply to be restored.
Mr Wilson’s legal representative at the hearing submitted to the Disciplinary Committee that granting the application would be in the public interest on the basis that Mr Wilson was 68 years of age and had now retired from the profession and closed his practice, that he had dedicated his entire working life to veterinary practice, had a previously long and unblemished career with no other complaints, and that he was well-regarded by clients and professional colleagues.
The application was not opposed by the RCVS whose representative informed the Committee that, relating to the charge of dishonesty, the College had taken into account that the insurance claim form was not submitted by Mr Wilson himself, and that there is no evidence of any financial motivation behind the charge nor any allegation of harm to an animal.
Taking into account the submissions from Mr Wilson’s representatives and from the RCVS, as well as precedent cases for such applications, the Committee decided that Mr Wilson’s voluntary undertakings went well beyond any sanction that could be imposed by the Committee and considered that the application would protect the public interest, confidence in the profession, and the welfare of animals.
Professor Alistair Barr FRCVS, chairing the Disciplinary Committee and speaking on its behalf, said: “The Committee decided that this is not a case in which the public interest or the welfare of animals demands that there be a full hearing, with determinations made by the Disciplinary Committee. Taking into account proportionality, and weighing in the balance the public interest, the interests of justice, the need to protect the welfare of animals, as well as the interests of both parties, the Committee decided to accede to the respondent’s application.”
The full findings of the Disciplinary Committee can be found at www.rcvs.org.uk/disciplinary
Research commissioned by Bayer Animal Health has revealed that dogs really do look like their owners.
The research, which is being used to promote Drontal Bone, the company's new bone-shaped wormer, was conducted amongst 3,000 British dog-lovers. It found that the overwhelming majority of owners share at least one common physical attribute with their pet, whilst one in ten owners could be described as the spitting image of their dog, sharing six or more physical attributes:
As part of the campaign, Bayer has launched the Give Your Dog a Bone competition, a nationwide search to find the UK's "Top Dog". The competition is split into four video and photographic categories, with one open exclusively to dogs that have formed a special bond with their owner. Top dogs can enter via the competition website - www.giveyourdogabone.co.uk - where owners can upload photos, videos, and explain in under 100 words why they think their pet should win a Drontal 'Bonies' award.
Give Your Dog a Bone Judge Emma Milne MRCVS, said: "When dogs seem to have the same characteristics as their owners, it could be because people subconsciously choose a pet that resembles themselves. It is often found that more energetic breeds, such as s Red Setter have an owner who is sporty and most happy when taking their pet on long country walks, while a glamorous owner who enjoys grooming themselves might choose a dog which also requires lots preening, such as a Maltese Terrier. The Give Your Dog a Bone awards give us the chance to recognise the unique traits and talents that make dogs such an important part of our lives. With four very different categories, this competition will be wide open to dogs of all shapes, sizes and personalities!"
Danilon is used to relieve the pain caused by musculoskeletal conditions, such as osteoarthritis (OA), bursitis, laminitis, and soft tissue inflammation.
Some oral NSAIDs have been shown to increase the risk of gastric irritation¹ - a particular concern when treating of chronic conditions.
However, Animalcare points to a study² in which horses given Danilon Gold showed a reduced number of ulcers and those that did appear were less severe.
The area of gastric mucosa affected was also five times less.
Animalcare says accurate administration is critical for clinical success.
To support this, Danilon Gold is presented in a coloured granule formulation and is now available in both 3g and 10g sachets.
Matthew, who holds a European Certificate in Small Animal Surgery, is one of a small group of veterinary dentists in the UK. He has a special interest in the endodontic (root canal) treatment of teeth.
Ray Girotti, Hospital Director at Lumbry Park, said: "The increasing prevalence of oral and dental disease among dogs and cats and its potential to cause significant pain and infection, not just in the oral cavity but within the whole body, highlights the importance of advanced dental care.
"We are delighted to be working with Matthew. He will be accepting referrals for a range of dental problems, including fractured teeth, root canal treatment, prosthetic crowns, fractured jaws, oral tumours and orthodontics.
"In leading our dental referral service, he will work alongside our specialist teams in cardiology, internal medicine, orthopaedics, neurology, diagnostic imaging and anaesthesia to ensure that we are providing a full service and comprehensive approach to the care of our patients."
Matthew added: "I’m excited to be launching a new dental referral service at Lumbry Park. The advanced facilities it offers, including the capability to work with specialist anaesthetists and to utilise the latest in-house 3D CT and MRI imaging equipment, make it a fantastic opportunity and I’m looking forward to working closely with my colleagues to deliver an outstanding dental referral service."
Cryptisel is for use in reducing oocyst shedding in calves where diarrhoea caused by Cryptosporidium is a problem. After the presence of the causal organism has been established, Forte says Cryptisel can be used in all new-born calves to break the cycle of transmission and multiplication on-farm.
Dr John Henderson, Large Animal Product Manager with Forte Healthcare Ltd said: "Cryptisel will be a very useful medicine in the control of the most commonly-identified scour pathogen in the UK and Ireland. Used alongside the calf-rearing cornerstones of good colostrum management, hygiene, and biosecurity, Cryptisel will reduce production of Cryptosporidium oocysts and help limit spread of the disease among susceptible calves."
Cryptisel is a POM, available in 490ml and 980ml bottles. Both sizes come with a metered dosing pump for convenient administration.
For further information, contact your local Forte Territory Manager or email enquiries@fortehealthcare.com.
Dr Mostert admitted to his conviction but denied that it rendered him unfit to practise as a veterinary surgeon.
He also admitted not disclosing his conviction to the RCVS but denied that it amounted to dishonesty or was misleading and that failing to do so amounted to disgraceful conduct in a professional respect.
The Committee first considered whether Dr Mostert’s conviction affected the public interest, which included the need to maintain public confidence in the profession by upholding proper standards of conduct and behaviour for members of the profession.
The Committee noted that the conviction involved dishonesty relating to false statements about the value of goods sent to the USA.
The Committee felt that a conviction for a serious offence involving dishonesty would have a negative impact on public confidence in the profession, and that its reputation would be damaged if proper standards of conduct and behaviour were not upheld.
The Committee also noted that as the products that Dr Mostert imported into the USA were not labelled as coming from a foreign market and were not labelled as needing to be administered by a vet, his conviction also related to animal safety, as anyone who accessed the medications could believe that it was safe for them to be given to an animal.
The Committee then considered Dr Mostert’s failure to declare the conviction to the College on three separate occasions.
Dr Mostert testified that, at the time, he did not believe he had to disclose his conviction as it occurred in a country where he had not practised as a veterinary surgeon.
He also said he had not taken the time to read and interpret the application form accurately.
However, the Committee considered that the wording around convictions on the application and annual renewal forms is very clear and that, as a veterinary surgeon, Dr Mostert would be familiar with such documents.
The Committee considered that it was inconceivable that an experienced veterinary surgeon, making a declaration of this kind to his regulator, would not have understood that a serious conviction in the USA, dating from June 2017, was a conviction that he was obliged to disclose.
The Committee therefore found Dr Mostert’s failures to declare his conviction dishonest.
Judith Way, Chairing the Committee and speaking on its behalf, noted that in deciding upon the appropriate sanction, the case did not involve any actual harm to an animal or human and that Dr Mostert had had a long and otherwise unblemished career.
However, a key aggravating factor was that the action that led to the conviction resulted in financial gain through the creation of a business enterprise and that Dr Mostert falsely declared the value of goods.
The extent of any financial gain was not known to the Committee, but the business operated on the basis that false declarations were repeatedly made.
Judith said: “After careful consideration the Committee has concluded that in all the circumstances, a lengthy period of suspension would properly reflect the gravity of the case and satisfy the public interest. The Committee has decided that the appropriate length of suspension is one of 18 months.”
The Committee’s full findings can be viewed at www.rcvs.org.uk/disciplinary
The Vet Channel has launched VetPod, a customisable video display system for practice waiting rooms.
The VetPod system is comprised of three elements: a website where you select the media you want to display in your waiting room, the VetPod, which downloads the videos you select, and a monitor on which to display them in your waiting room.
The Vet Channel says it is updating its media library regularly, so you can pick content which ties in with your practices' clinical focus, marketing strategy and promotional offerings.
The system also allows you to upload your own logos, photographs and videos, and display practice specific information, such as staff news, opening hours, special clinics and promotions. In addition The Vet Channel's in-house design studio can create bold, eye-catching media content to reflect your brand and promote every aspect of your services.
Anthony Beliovich from Companion Care said: "Enquiries about microchipping and flea treatment increased by 25% after we installed The Vet Channel."
For more information, visit http://www.thevetchannel.co.uk/, email enquiries@thevetchannel.co.uk, or ring: 0844 8111406
Alternatively, you'll be able to see a demonstration of VetPod at BSAVA Congress this year.